These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8090036)

  • 1. Detection of serum anti p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia.
    Preudhomme C; Lubin R; Lepelley P; Vanrumbeke M; Fenaux P
    Leukemia; 1994 Sep; 8(9):1589-91. PubMed ID: 8090036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
    Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
    Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
    Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
    Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.
    Venkatraj VS; Gaidano G; Auerbach AD
    Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan.
    Wu CM; Tang R; Chen JR; Wu MC; Chien HT; Changchien CR; Hsieh LL
    Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum anti-p53 in relation to mutations across the entire translated p53 gene in colorectal carcinomas.
    Forslund A; Kressner U; Lindmark G; Inganäs M; Lundholm K
    Int J Oncol; 2001 Sep; 19(3):501-6. PubMed ID: 11494027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
    Lai JL; Preudhomme C; Zandecki M; Flactif M; Vanrumbeke M; Lepelley P; Wattel E; Fenaux P
    Leukemia; 1995 Mar; 9(3):370-81. PubMed ID: 7885035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia.
    Nakai H; Misawa S; Tanaka S; Nishigaki H; Taniwaki M; Yokota S; Horiike S; Takashima T; Seriu T; Nakagawa H
    Leukemia; 1993 Oct; 7(10):1547-51. PubMed ID: 8412316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells.
    Zhang W; Hu G; Estey E; Hester J; Deisseroth A
    Oncogene; 1992 Aug; 7(8):1645-7. PubMed ID: 1630824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of p53 mutations using nonradioactive SSCP analysis: p53 is not frequently mutated in myelodysplastic syndromes (MDS).
    Neubauer A; Brendel C; Vogel D; Schmidt CA; Heide I; Huhn D
    Ann Hematol; 1993 Nov; 67(5):223-6. PubMed ID: 8241345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of temperature-sensitive mutations of p53 tumor suppressor in acute myeloid leukemia revealed by functional assay in yeast.
    Pavlova S; Mayer J; Koukalova H; Smardova J
    Int J Oncol; 2003 Jul; 23(1):121-31. PubMed ID: 12792784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between p53 gene mutations and multidrug resistance (mdr1) gene expression in myelodysplastic syndromes.
    Preudhomme C; Lepelley P; Vachee A; Soenen V; Quesnel B; Cosson A; Fenaux P
    Leukemia; 1993 Nov; 7(11):1888-90. PubMed ID: 7901457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of TP53 and FMS gene mutations in children with myelodysplastic syndrome.
    Jekic B; Novakovic I; Lukovic L; Kuzmanovic M; Popovic B; Milasin J; Bunjevacki G; Damnjanovic T; Cvjeticanin S; Bunjevacki V
    Cancer Genet Cytogenet; 2006 Apr; 166(2):163-5. PubMed ID: 16631474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.
    Tolbert DM; Noffsinger AE; Miller MA; DeVoe GW; Stemmermann GN; Macdonald JS; Fenoglio-Preiser CM
    Mod Pathol; 1999 Jan; 12(1):54-60. PubMed ID: 9950163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the p53 gene in myelodysplastic syndrome and overt leukemia.
    Mori N; Hidai H; Yokota J; Okada M; Motoji T; Oshimi K; Mizoguchi H
    Leuk Res; 1995 Nov; 19(11):869-75. PubMed ID: 8551805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies.
    Wattel E; Preudhomme C; Hecquet B; Vanrumbeke M; Quesnel B; Dervite I; Morel P; Fenaux P
    Blood; 1994 Nov; 84(9):3148-57. PubMed ID: 7949187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular study on minute alterations of the p53 and the N-ras genes in hematologic malignancies].
    Kurosawa M
    Hokkaido Igaku Zasshi; 1994 May; 69(3):543-54. PubMed ID: 7927179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 mutation in advanced stage of primary myelodysplastic syndrome.
    Tang JL; Tien HF; Lin MT; Chen PJ; Chen YC
    Anticancer Res; 1998; 18(5B):3757-61. PubMed ID: 9854490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the p53 gene in myelodysplastic syndromes.
    Jonveaux P; Fenaux P; Quiquandon I; Pignon JM; Laï JL; Loucheux-Lefebvre MH; Goossens M; Bauters F; Berger R
    Oncogene; 1991 Dec; 6(12):2243-7. PubMed ID: 1766671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancer.
    Leonard DG; Travis LB; Addya K; Dores GM; Holowaty EJ; Bergfeldt K; Malkin D; Kohler BA; Lynch CF; Wiklund T; Stovall M; Hall P; Pukkala E; Slater DJ; Felix CA
    Clin Cancer Res; 2002 May; 8(5):973-85. PubMed ID: 12006509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.